$MNKD News Skullcandy gains on upgrade,Tesla reverses

New Post Public Reply Private Reply Replies (0) Message Board

Aug 26, 2014 at 12:00 PM

$MNKD News

Skullcandy gains on upgrade,Tesla reverses gains 2:37 p.m. Aug. 12, 2014 - Sue Chang
U.S. small caps lead broad stock-market gains 4:09 p.m. Aug. 11, 2014 - Anora Mahmudova
Kinder Morgan soars, Tesla rallies on upgrade 12:46 p.m. Aug. 11, 2014 - Sue Chang
MannKind shares soar on Sanofi deal; investors ignore earnings report 10:10 a.m. Aug. 11, 2014 - Russ Britt
Super-Moon illusion or buy the dips on this stock market? 7:52 a.m. Aug. 11, 2014 - Barbara Kollmeyer
MannKind shares soar 23% on Sanofi deal over Afrezza 7:04 a.m. Aug. 11, 2014 - Silvia Ascarelli
Sanofi, MannKind to commercialize Afrezza insulin therapy 5:32 a.m. Aug. 11, 2014 - Silvia Ascarelli
Puma Biotech’s blast-off is not a typical short squeeze 12:10 p.m. July 23, 2014 - Tomi Kilgore
S&P 500 posts strongest 2nd quarter since 2009: Stock market live blog recap 3:33 p.m. June 30, 2014 - blogs.marketwatch.com
MannKind, GoPro rise; Yahoo gains on upgrade 12:02 p.m. June 30, 2014 - Sue Chang
MannKind shares up 23.1% in premarket trade 7:19 a.m. June 30, 2014 - Ciara Linnane
Six more bull months ahead, and GoPro keeps on going 6:28 a.m. June 30, 2014 - Sara Sjolin
MannKind wins approval for its inhaled insulin — and its stock drops? 4:30 p.m. June 27, 2014 - Russ Britt
DuPont falls on outlook; Michaels debuts 4:08 p.m. June 27, 2014 - Sue Chang
3 overlooked stocks loved by top-ranked advisers 3:09 p.m. April 25, 2014 - Mark Hulbert
Tesla, Facebook seesaw; Questcor surges on deal 3:54 p.m. April 7, 2014 - Sue Chang
MannKind drops after FDA says its review on drug will last until July 1:46 p.m. April 7, 2014 - Russ Britt
Stock futures drop as earnings season looms 9:20 a.m. April 7, 2014 - Sara Sjolin
MannKind drops 12% after FDA review extension 7:15 a.m. April 7, 2014 - Ben Eisen
MannKind drops 16% after FDA review extension 7:01 a.m. April 7, 2014 - Ben Eisen

MannKind Is Ripe: Let's Do Big Things, But Fundamentals First 8:49 a.m. Today - Seeking Alpha
Biggest Movers in Healthcare Stocks Now – ACHN IRWD PCRX CBST 1:45 p.m. Aug. 25, 2014 - InvestorPlace.com
MannKind: Moving From Short To Long? 1:04 p.m. Aug. 25, 2014 - Seeking Alpha
Roche to Acquire InterMune and Deliver Hope to Patients Worldwide 10:16 a.m. Aug. 25, 2014 - GuruFocus.com
5 Stocks With Bad Sales Growth — HTS MITT UEC MNKD CTEL 6:00 a.m. Aug. 25, 2014 - InvestorPlace.com
How Sanofi's Growth Strategy Will Catapult Afrezza Into a Blockbuster Drug 12:43 p.m. Aug. 20, 2014 - GuruFocus.com
MannKind Corporation: Back To The Fundamentals 11:50 a.m. Aug. 20, 2014 - Seeking Alpha
Revisiting Arena, Orexigen, And VIVUS: Shareholders Can Recoup Their Losses By Invest In MannKind 2:31 p.m. Aug. 19, 2014 - GuruFocus.com
Hottest Healthcare Stocks Now – CLDX KND PDLI MNKD 7:30 a.m. Aug. 19, 2014 - InvestorPlace.com
MannKind Corp. And The Folly Of Cult Biotech Stocks 8:51 a.m. Aug. 18, 2014 - Seeking Alpha
Hottest Healthcare Stocks Now – LCI HMSY CBPO MNKD 8:45 a.m. Aug. 18, 2014 - InvestorPlace.com
5 Stocks With Awful Sales Growth — HTS MITT UEC MNKD CTEL 4:00 a.m. Aug. 18, 2014 - InvestorPlace.com
Evaluating MannKind (MNKD) & Sanofi (SNY) Agreement for Afrezza 8:59 a.m. Aug. 15, 2014 - GuruFocus.com
10 Known Unknowns That Matter For MannKind Investors 4:45 p.m. Aug. 14, 2014 - Seeking Alpha
There is a Tide in the Affairs of MannKind: When Taken At the Flood, Will Lead to Fortune 3:38 p.m. Aug. 14, 2014 - GuruFocus.com
10 Cheap Stocks to Buy Now Under $10 10:20 a.m. Aug. 14, 2014 - InvestorPlace.com
Properly Treating Costs: Re-Evaluating The MannKind And Sanofi Partnership 4:53 p.m. Aug. 13, 2014 - Seeking Alpha
Blame MannKind's Fall on its Bloated Balance Sheet 12:04 p.m. Aug. 13, 2014 - TheStreet.com
Update: MannKind Q2 Earnings - Stock Sent To The Woodshed 10:14 a.m. Aug. 13, 2014 - Seeking Alpha
MannKind Corporation (MNKD): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 8:00 a.m. Aug. 13, 2014 - Zacks.com

Drug Approvals & Updates, Licensing Agreements, and Upcoming Conferences - Research Reports on Tekmira, MannKind, Eli Lilly, GSK and Cigna 8:30 a.m. Aug. 14, 2014 - PR Newswire - PRF
Critical Alerts For MannKind, Kinder Morgan, Kohls, Maxim Integrated Products and United Technologies. Released By InvestorsObserver 9:31 a.m. Aug. 12, 2014 - PR Newswire - PRF
MannKind Corporation Reports 2014 Second Quarter Financial Results 9:01 a.m. Aug. 11, 2014 - GlobeNewswire
Sanofi and MannKind Announce Global Licensing Agreement for Afrezza® (insulin human) Rapid-Acting Inhaled Insulin 7:00 a.m. Aug. 11, 2014 - PR Newswire - PRF
Sanofi and MannKind Announce Global Licensing Agreement for Afrezza(R) (insulin human) Rapid-Acting Inhaled Insulin 1:13 a.m. Aug. 11, 2014 - GlobeNewswire
MannKind Corporation to Hold 2014 Second Quarter Financial Results Conference Call on August 11, 2014 5:00 p.m. Aug. 5, 2014 - GlobeNewswire
Biotech Stocks Technical Data -- MannKind, ARIAD Pharma, Galena Biopharma, Geron, and Peregrine Pharma 9:00 a.m. Aug. 1, 2014 - PR Newswire - PRF
Critical Alerts For MannKind, CVS Caremark, Express Scripts, Cheniere Energy, and HomeAway Released By InvestorsObserver 9:31 a.m. July 21, 2014 - PR Newswire - PRF
NDA Submission, Results Release Schedules, FDA Grants and Approvals, and Agreements - Analyst Notes on Gilead, Biogen Idec, Amgen, Illumina and MannKind 5:20 a.m. July 4, 2014 - PR Newswire - PRF
MannKind Corp Analyst Report; Afrezza is Approved and Future Developments by BrokerBank Securities, Inc. 11:15 a.m. July 3, 2014 - PR Newswire - PRF
Critical Alerts For MannKind, AOL, Plug Power, Ctrip.com, and 58.com Released By InvestorsObserver 9:31 a.m. July 1, 2014 - PR Newswire - PRF
MannKind Corporation Announces FDA Approval of AFREZZA(R); A Novel, Rapid-Acting Inhaled Insulin for the Treatment of Diabetes 5:07 p.m. June 27, 2014 - GlobeNewswire
Leadership Appointments, Approved Acquisitions, Licensing Agreements, Technical UPdate, and Response to Tender Offer Announcement - Analyst Notes on Actavis, Forest, Vertex, MannKind and Gentiva 5:20 a.m. June 26, 2014 - PR Newswire - PRF
Critical Alerts For Netflix, MannKind, Dish Network, Illumina, and Anheuser-Busch InBev Technology Released By InvestorsObserver 9:31 a.m. June 6, 2014 - PR Newswire - PRF
MannKind to Present at Upcoming Conferences 9:01 a.m. May 27, 2014 - GlobeNewswire
Reveal Insider Trading for Facebook, MannKind, QUALCOMM, American Realty Capital Properties, salesforce.com, and Symantec 8:55 a.m. May 22, 2014 - PR Newswire - PRF
Technical Data on Top Gainers -- Research on MannKind, Intermolecular, FireEye, and Yingli Green Energy Holding 9:10 a.m. May 20, 2014 - PR Newswire - PRF
Earnings Release Results, and Leadership Appointments - Analyst Notes on Halozyme, MannKind, Arrowhead, Idera and BioCryst 7:00 a.m. May 16, 2014 - PR Newswire - PRF
Critical Alerts For Citigroup, Linn Energy, MannKind, Canadian Solar, and Qualcomm Released By InvestorsObserver 9:31 a.m. May 15, 2014 - PR Newswire - PRF
MannKind Corporation Pending FDA Approval Inspires Analyst Report by BrokerBank Securities, Inc. 8:00 a.m. May 14, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sandbox VR Expands to Melbourne, Betting on Immersive Fun

Sandbox VR Ventures into Melbourne's Heart Every now and then, a venture takes its ambitions and rolls the dice on a prime location. Sandbox VR is swaggering into Melbourne's bustling Central Business District, fresh out of its success on the Gold Coast. Opening this Melbourne venue on September 14 marks a significant leap in the company's Aussie expansion—a bold nod to...

ZEEKR's Shooting Brakes Dominate: Over 400K Sold

ZEEKR's Stellar Performance in a Crowded Market Another month, another bumper crop for ZEEKR's shooting brakes. These beauties aren't just hanging in there; they're leading the pack. In August alone, global deliveries marched past the 10,000 mark for the third month running—a feat not easily achieved in today's saturated automotive landscape. It's no wonder the...

LeoLabs and SciTec Partner for $93.7M Space Force Deal

LeoLabs and SciTec Join Forces for Space Dominance The space race ain't just about rockets blasting off anymore. It's about making sure we've got eyes everywhere, even on the back of our heads, so to speak. Enter LeoLabs teaming up with SciTec to help the U.S. Space Force upgrade their radar systems to something out of a sci-fi flick, armed with a $93.7 million contract...

Law Firm Gains Strength with Strategic New Hires

Catching the latest twist in the legal scene, veteran criminal defense attorney John T. Floyd is stiffening the backbone of his Houston-based firm. Snagging both Christopher Choate and Mia Floyd, he's set to fortify his team representing folks caught in the snarl of Texas and federal criminal courts. New Faces, Massive Expertise Let's dig into Choate's credentials first....

Veho's Role in Redefining Beauty E-Commerce Delivery

Veho Grabs Headlines with BeautyMatter Awards Nod Here's something a bit off the beaten path: Veho's been tapping into new wells of opportunity in the e-commerce sector, and their latest accolade demonstrates just that. Named a finalist in the 2026 BeautyMatter Awards under the Logistics category, they're making noise in all the right circles. Beyond Boxes: Transforming...

Midlife ADHD in Women: New Challenges and Solutions

ADHD Evolution in Women's Midlife They say change is the only constant, and boy, does that ring true for women navigating the turbulent seas of ADHD as they hit 40 and beyond. According to Germaine Swanson, the ADHD landscape changes dramatically in midlife, especially for women. We're talking about a mix of hormonal shifts, increasing life demands, and changes in brain...

Push Notification Security Transforms Healthcare IT Support

Cutting the Fat on IT Help Desk Bottlenecks Healthcare IT teams are fighting an uphill battle with password resets, a mundane task consuming up to half of all help desk calls. It's like trying to stop a leaking dam with duct tape. For health systems, these calls aren't just a minor annoyance—they're a full-fledged budget hog. Try telling a CIO that an agent-friendly...

Cove Capital Secures $9.96M for Debt-Free Logistics DST

Unpacking Cove Capital's Latest Victory Cove Capital Investments has pulled off another coup, raising a hefty $9,964,510 for its Cove Essential Net Lease Industrial 108 DST. It's a Regulation D, Rule 506(c) offering, now fully subscribed, spotlighting a debt-free investment ethos and a rock-solid logistics site in Anchorage, Alaska. Strategic Facility Anchoring Investment...

Tampa General’s Innovation Excellence Earns No. 20 Spot

A Bold Leap into Innovation at Tampa General There's a heck of a lot going on down in Tampa that's worth more than just a golf clap. Tampa General Hospital (TGH) just snagged the 20th spot on Fast Company's Best Workplaces for Innovators list, and let me tell you, that’s no small feat amidst the heavy hitters in verticals like biotech and consumer goods. It takes guts...

RevSystems Joins Elite OpenAI Partner Network

RevSystems Inks Deal with OpenAI Partner Network In the latest shuffle of the AI advisory deck, RevSystems just found itself elbowing into the exclusive OpenAI Partner Network. Based out of New York, RevSystems has carved a niche by spinning tech wizardry into tangible business results. Their new status as an OpenAI Select Partner puts them on a playing field where AI...